IL17A and fibrosis: The IL17A-G197A GA and AA genotypes were more frequent in patients with advanced liver fibrosis compared to those with no fibrosis (GA genotype frequency: 42.9% vs. 7.7%; AA genotype frequency: 14.3% vs. 5.1%; adjusted p = 0.0423) and were also more prevalent in patients with mild to moderate liver fibrosis compared to those with no fibrosis (GA genotype frequency: 40.0% vs. 7.7%; AA genotype frequency: 11.4% vs. 5.1%; adjusted p = 0.0014).